Table 2.
Clinical characteristics of the patients.
| Characteristics | All (n = 40) | Mild (n = 27) | Severe (n = 13) | P |
|---|---|---|---|---|
| Age (years), mean ± SD | 43.93 ± 2.09 | 45.04 ± 2.56 | 41.62 ± 3.67 | 0.4492 |
| Male, n (%) | 22 (55.00%) | 15 (55.56%) | 7 (53.85%) | 0.99∗ |
| BMI (kg/m2) | 20.32 ± 0.47 | 20.53 ± 0.56 | 19.9 ± 0.88 | 0.5314 |
| Donor, n (%) | 0.1540∗ | |||
| DCD | 35 (87.50) | 22 (81.48) | 13 (100.00) | |
| Relative | 5 (12.50) | 5 (18.52) | 0 (0.00) | |
| Time since transplantation (months), median ± IQR | 8.07 ± 22.45 | 10.93 ± 25.08 | 7.20 ± 5.50 | 0.1140# |
| CNI, n (%) | 0.99∗ | |||
| FK506 | 38 (95.00) | 26 (96.30) | 12 (92.31) | |
| CSA | 2 (5.00) | 1 (3.70) | 1 (7.69) | |
| Survival, n (%) | 36 (90.00) | 27 (100) | 9 (69.23) | 0.0078∗ |
| Hospital stay period (days), median ± IQR | 16 ± 17.50 | 13 ± 13.50 | 34 ± 25 | 0.0078# |
| WBC (109/L), median ± IQR | 7.52 ± 4.45 | 7.69 ± 3.37 | 6.95 ± 6.57 | 0.2865# |
| PLT (109/L), median ± IQR | 201 ± 96.25 | 202 ± 80.5 | 198 ± 138 | 0.6430# |
| BUN (mmol/L), median ± IQR | 9.21 ± 10.81 | 7.12 ± 5.79 | 17.26 ± 8.76 | 0.0002# |
| Cr admission (μmol/L), median ± IQR | 123 ± 68.25 | 119 ± 63 | 155 ± 255 | 0.0242# |
| CRP (mg/L), median ± IQR | 37.45 ± 54.59 | 36.72 ± 53.04 | 41.13 ± 97.08 | 0.3423# |
| Procalcitonin (ng/mL), median ± IQR | 0.10 ± 0.33 | 0.06 ± 0.16 | 0.24 ± 7.34 | 0.0030# |
| Albumin (g/L) | 37.0 ± 6.23 | 39.3 ± 5.46 | 32.38 ± 5.09 | 0.0005 |
| Ca+ (mmol/L), median ± IQR | 2.40 ± 0.24 | 2.45 ± 0.13 | 2.26 ± 0.33 | 0.1324# |
SD: standard deviation; IQR: interquartile range; DCD: donation after citizens' death; CNI: calcineurin inhibitor; CsA: cyclosporine A; BUN: blood urea nitrogen; Cr: serum creatinine; CRP: C reactive protein; ∗tested by Fisher's exact test; #tested by Mann-Whitney U test.